Gemcitabine | Shrader & Associates L.L.P.
Get in Touch Today


Over A Billion Recovered Nationwide

Gemcitabine (brand name Gemzar)

This belongs to the drug class known as nucleoside analogs, meaning they have similar properties to the compound nucleoside that occurs naturally in the body. Gemcitabine is converted inside the cell to difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP). This results in the drug working in two ways. The dFdCDP stops the enzyme ribonucleotide reductase from doing its job of converting ribonucleotides to deoxyribonucleotides. Without this conversion, new DNA cannot be created so that cells can divide to form new cells and damaged DNA can’t be repaired. The second action is that the dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis, or automatic cell death.

This is another drug that doesn’t differentiate between cancerous cells and normal cells, so it will work on any rapidly dividing cell. One of the side effects of this drug is the killing off of the rapidly dividing stem cells of the bone marrow, which can cause anemia.

There are common side effects to using gemcitabine including:

  • Feeling of “crawling” on the skin or itching
  • Constipation or diarrhea
  • Drowsiness
  • Flu-like symptoms, such as fever, cough, chills, and muscle aches
  • Hair loss
  • Loss of appetite
  • Nausea (with the possibility of vomiting)
  • Sleepiness
  • Small red spots below the surface of the skin

These side effects generally disappear after treatment has been completed.

There are more severe side effects; however, which require an immediate call to the doctor:

  • Allergic reactions, such as rash, hive, difficulty breathing, tightness in the chest, swelling of the face, lips, or tongue
  • Abdominal pain
  • Confusion or a feeling of being disoriented
  • Dark urine, blood in the urine, painful or frequent urinating, difficulty urinating or decreased amount of urine
  • Irregular or missed menstrual periods
  • Irregular heartbeat
  • Joint or muscle pain or numbness in the arms or legs
  • Hallucinations
  • Seizures
  • Unusual bruising or bleeding
  • Extreme fatigue
  • Yellowing of the skin or eyes
  • Swelling of the hands or feet

The combination of gemcitabine and cisplatin is recommended for the first-line chemotherapy treatment of patients with inoperable, locally advanced, or metastatic tumors. There are two possible schedules for the administration of these drugs; however, according to the drug manufacturer, Eli Lilly, neither one has been proven to be more effective than the other.

Using the 4-week schedule, gemcitabine is administered intravenously at 1000 mg/m2 (megagrams per square meter) over 30 minutes on Days 1, 8, and 15 of each 28-day cycle. Cisplatin is administered intravenously at 100 mg/m2 on Day 1 after the gemcitabine.

Using the 3-week schedule, gemcitabine is administered intravenously at 1250 mg/m2 over 30 minutes on Days 1 and 8 of each 21-day cycle. Cisplatin is administered intravenously at a dose of 100 mg/m2 on Day 1 after the gemcitabine.

The doctor may have to adjust the dosage for blood toxicity based on the granulocyte (a type of white blood cell) and platelet counts taken on the day of therapy. If bone marrow suppression is discovered, therapy should be modified or suspended depending upon the severity of the situation. In addition, creatinine (metabolic waste product found in urine that is an indicator of kidney function), potassium, calcium, and magnesium should be carefully monitored.

Contact Us Today

Request a Free Consultation

    Mesothelioma Lawsuit
    Mesothelioma Lawsuit

    We Take Our Clients’ Cases Personal

    Helping Victims of Mesothelioma Is Why We Do What We Do

    Your firm has made this stressful process easy and comfortable for me.

    “In this difficult time for me, everyone in your office has been helpful and supportive in ensuring that not only are our objectives with my case met but also that my personal needs are accommodated.”
    - Stephen

    I couldn’t have done it without you.

    “My case was complex, but you untangled the details of my asbestos exposure so that they were clear in court.”
    - Sam

    The professionals at Shrader & Associates did the work, hassle free, and ensured I was able to leave a legacy for my family.

    “I hesitated to file suit because I thought going to trial would be a hassle. The professionals at Shrader & Associates did the work, hassle-free, and ensured I was able to leave a legacy for my family ...”
    - Raymond

    Your team stood by me throughout the entire process.

    “The future looks a bit brighter for my family now.”
    - Frank

    Thanks to you, the grief of my loss would have been almost unbearable otherwise.

    “The wonderful things you have done for us, the things you have made possible for my family, the doors you have opened – I will always be grateful.”
    - Brian

    Experience You Can Count On

    Our Awards & Accolades


    The Right Team Makes a Difference

    Mesothelioma cases require technical knowledge and an understanding of complex laws. An attorney with experience trying these claims and substantial resources to leverage on your behalf is your best bet to having a strong case. We are nationally recognized for providing quality representation to mesothelioma patients and their families.

    Meet Our Attorney

    Choosing the Right Law Firm is an Important & Personal Decision

    Why Shrader & Associates?


    Our skilled approach to the practice of law has resulted in top ratings & awards from renowned legal organizations.


    Our attorneys have been invited into some of the most prestigious and recognized professional associations in the U.S.


    We’ve been featured on local and national news programs for our legal knowledge and winning results.


    To date, we’ve secured countless million-dollar results for clients located throughout the country.